Clinical trial
A Study to Assess the Effectiveness of Teriparatide (FORTEO) for Increasing Bone Mass and Improving Bone Strength in Adults Affected With Osteogenesis Imperfecta (OI)
NCT00131469 is registered in ClinicalTrials.gov with Oregon Health and Science University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study to Assess the Effectiveness of Teriparatide (FORTEO) for Increasing Bone Mass and Improving Bone Strength in Adults Affected With Osteogenesis Imperfecta (OI)
- Lead sponsor
- Oregon Health and Science University
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- June 30, 2005
- Completion date
- January 31, 2011
- Enrollment
- 79 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.